Literature DB >> 21889221

Prostate HDR brachytherapy catheter displacement between planning and treatment delivery.

May Whitaker1, George Hruby, Aimee Lovett, Nitya Patanjali.   

Abstract

BACKGROUND AND
PURPOSE: HDR brachytherapy is used as a conformal boost for treating prostate cancer. Given the large doses delivered, it is critical that the volume treated matches that planned. Our outpatient protocol comprises two 9 Gy fractions, two weeks apart. We prospectively assessed catheter displacement between CT planning and treatment delivery.
MATERIALS AND METHODS: Three fiducial markers and the catheters were implanted under transrectal ultrasound guidance. Metal marker wires were inserted into 4 reference catheters before CT; marker positions relative to each other and to the marker wires were measured from the CT scout. Measurements were repeated immediately prior to treatment delivery using pelvic X-ray with marker wires in the same reference catheters. Measurements from CT scout and film were compared. For displacements of 5mm or more, indexer positions were adjusted prior to treatment delivery.
RESULTS: Results are based on 48 implants, in 25 patients. Median time from planning CT to treatment delivery was 254 min (range 81-367 min). Median catheter displacement was 7.5mm (range -2.9-23.9 mm), 67% of implants had displacement of 5mm or greater. Displacements were predominantly caudal.
CONCLUSIONS: Catheter displacement can occur in the 1-3h between the planning CT scan and treatment. It is recommended that departments performing HDR prostate brachytherapy verify catheter positions immediately prior to treatment delivery. Crown
Copyright © 2011. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21889221     DOI: 10.1016/j.radonc.2011.08.004

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

1.  Improved electromagnetic tracking for catheter path reconstruction with application in high-dose-rate brachytherapy.

Authors:  Elodie Lugez; Hossein Sadjadi; Chandra P Joshi; Selim G Akl; Gabor Fichtinger
Journal:  Int J Comput Assist Radiol Surg       Date:  2017-02-18       Impact factor: 2.924

2.  Intraoperative 360-deg three-dimensional transvaginal ultrasound during needle insertions for high-dose-rate transperineal interstitial gynecologic brachytherapy of vaginal tumors.

Authors:  Jessica Robin Rodgers; Jeffrey Bax; Kathleen Surry; Vikram Velker; Eric Leung; David D'Souza; Aaron Fenster
Journal:  J Med Imaging (Bellingham)       Date:  2019-04-08

Review 3.  Review of advanced catheter technologies in radiation oncology brachytherapy procedures.

Authors:  Jun Zhou; Leonid Zamdborg; Evelyn Sebastian
Journal:  Cancer Manag Res       Date:  2015-07-16       Impact factor: 3.989

4.  Improved prostate delineation in prostate HDR brachytherapy with TRUS-CT deformable registration technology: A pilot study with MRI validation.

Authors:  Xiaofeng Yang; Peter J Rossi; Ashesh B Jani; Hui Mao; Zhengyang Zhou; Walter J Curran; Tian Liu
Journal:  J Appl Clin Med Phys       Date:  2017-01       Impact factor: 2.102

5.  Physics-aspects of dose accuracy in high dose rate (HDR) brachytherapy: source dosimetry, treatment planning, equipment performance and in vivo verification techniques.

Authors:  Antony Palmer; David Bradley; Andrew Nisbet
Journal:  J Contemp Brachytherapy       Date:  2012-06-30

6.  Prostate volume and implant configuration during 48 hours of temporary prostate brachytherapy: limited effect of oedema.

Authors:  Anna M Dinkla; Bradley R Pieters; Kees Koedooder; Niek van Wieringen; Rob van der Laarse; Arjan Bel
Journal:  Radiat Oncol       Date:  2014-12-11       Impact factor: 3.481

7.  Catheter displacement prior to the delivery of high-dose-rate brachytherapy in the treatment of prostate cancer patients.

Authors:  Shogo Kawakami; Hiromichi Ishiyama; Tsuyoshi Terazaki; Itaru Soda; Takefumi Satoh; Masashi Kitano; Shinji Kurosaka; Akane Sekiguchi; Shouko Komori; Masatsugu Iwamura; Kazushige Hayakawa
Journal:  J Contemp Brachytherapy       Date:  2014-06-24

8.  Robustness of IPSA optimized high-dose-rate prostate brachytherapy treatment plans to catheter displacements.

Authors:  Joel Poder; May Whitaker
Journal:  J Contemp Brachytherapy       Date:  2016-06-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.